Volume 34 Number 23 June 11-18, 2015
Reviews, News and Commentaries
The coming era of human phenotyping.
Nat. Biotechnol. 2015 Jun 9. 33(6) 567
Nat. Biotechnol. 2015 Jun 9. 33(6) 567
There's still a lot we don't know about the new cholesterol-lowering drugs, by Julia Belluz, Vox, June 11
by Julia Belluz, Vox, June 11A new way to treat high cholesterol? By Matt Sloane, Web MD, June 10
By Matt Sloane, Web MD, June 10New, potent cholesterol-lowering drug gets FDA advisory approval, by Carina Storrs, CNN, June 10
by Carina Storrs, CNN, June 10Panel tells F.D.A. to back second drug to help heart, by Gina Kolata, New York Times, June 10
by Gina Kolata, New York Times, June 10A surprising match: Cancer immunotherapy and mismatch repair, by Francis Collins, NIH Director?s Blog, June 9
by Francis Collins, NIH Director?s Blog, June 9Federal panel backs approval of new drug to fight heart attacks, by Gina Kolata, New York Times, June 9
by Gina Kolata, New York Times, June 9Genetic test for 'familial' heart risk extended, BBC, June 9
BBC, June 9Something interesting is happening, NIMH Director's Blog, June 9
NIMH Director's Blog, June 9Irreproducible biology research costs put at $28 billion per year, by Monya Baker, Nature News, June 9
by Monya Baker, Nature News, June 9In the future, treatments tailored to patients, by Robert Weisman, Boston Globe, June 6
by Robert Weisman, Boston Globe, June 6Why do healthy people have harmful mutations? By Ricki Lewis, PLOS Blogs, June 4
By Ricki Lewis, PLOS Blogs, June 4
.png)
No hay comentarios:
Publicar un comentario